FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210347170> ?p ?o ?g. }

• W3210347170 endingPage "1071" @default.
• W3210347170 startingPage "1063" @default.
• W3210347170 abstract "Retroperitoneal (RPS) sarcomas are associated with poor local and abdominal tumor control. However, the benefit of preoperative radio- or chemotherapy alone for these entities is currently unclear. Moreover, as intermediate- and high-grade sarcomas have a tendency toward early metastasis, exploration of neoadjuvant strategies is of high importance. This analysis reports the results of our 20-year single-institution experience with preoperative neoadjuvant concurrent chemoradiation.From 2000-2019, 27 patients with intermediate- or high-grade RPS (12 dedifferentiated liposarcoma, 10 leiomyosarcoma, 5 others) were treated with radiotherapy (median dose: 50.4 Gy; range 45-75 Gy) and two cycles of chemotherapy (doxorubicin 50 mg/m2 BSA/d3 q28 and ifosfamide 1.5 g/m2 BSA/d1‑5 q28) in neoadjuvant intent. Chemotherapy consisted of doxorubicin alone in two cases and ifosfamide alone in one case. Fifteen patients (56%) additionally received deep regional hyperthermia.The median follow-up time was 53 months (±56.7 months). 92% of patients received two cycles of chemotherapy as planned and 92% underwent surgery. At 5 and 10 years, abdominal-recurrence-free survival was 74.6% (±10.1%) and 66.3% (±11.9%), distant metastasis-free survival was 67.2% (±9.7%) and 59.7% (±11.1%), and overall survival was 60.3% (±10.5%) and 60.3% (±10.5%), respectively. CTC grade III and IV toxicities were leukocytopenia (85%), thrombocytopenia (33%), and anemia (11%). There were no treatment-related deaths.Neoadjuvant chemoradiotherapy with and without hyperthermia for retroperitoneal sarcomas is feasible and provided high local control of intermediate- and high-grade sarcoma." @default.
• W3210347170 created "2021-11-08" @default.
• W3210347170 creator A5005230207 @default.
• W3210347170 creator A5008757972 @default.
• W3210347170 creator A5010448955 @default.
• W3210347170 creator A5014096214 @default.
• W3210347170 creator A5020689634 @default.
• W3210347170 creator A5024236651 @default.
• W3210347170 creator A5027231637 @default.
• W3210347170 creator A5032895748 @default.
• W3210347170 creator A5034065380 @default.
• W3210347170 creator A5068410789 @default.
• W3210347170 creator A5078251698 @default.
• W3210347170 creator A5081135420 @default.
• W3210347170 creator A5086028372 @default.
• W3210347170 date "2021-11-04" @default.
• W3210347170 modified "2023-10-06" @default.
• W3210347170 title "Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome" @default.
• W3210347170 cites W1922694287 @default.
• W3210347170 cites W1994454605 @default.
• W3210347170 cites W2086177683 @default.
• W3210347170 cites W2100339026 @default.
• W3210347170 cites W2123377696 @default.
• W3210347170 cites W2125452425 @default.
• W3210347170 cites W2128668604 @default.
• W3210347170 cites W2153477869 @default.
• W3210347170 cites W2218684260 @default.
• W3210347170 cites W2318382946 @default.
• W3210347170 cites W2323526189 @default.
• W3210347170 cites W2528095575 @default.
• W3210347170 cites W2767006240 @default.
• W3210347170 cites W2787945010 @default.
• W3210347170 cites W2938272674 @default.
• W3210347170 cites W2984266236 @default.
• W3210347170 cites W3027587114 @default.
• W3210347170 cites W3086258129 @default.
• W3210347170 doi "https://doi.org/10.1007/s00066-021-01830-0" @default.
• W3210347170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8604874" @default.
• W3210347170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34735576" @default.
• W3210347170 hasPublicationYear "2021" @default.
• W3210347170 type Work @default.
• W3210347170 sameAs 3210347170 @default.
• W3210347170 citedByCount "6" @default.
• W3210347170 countsByYear W32103471702022 @default.
• W3210347170 countsByYear W32103471702023 @default.
• W3210347170 crossrefType "journal-article" @default.
• W3210347170 hasAuthorship W3210347170A5005230207 @default.
• W3210347170 hasAuthorship W3210347170A5008757972 @default.
• W3210347170 hasAuthorship W3210347170A5010448955 @default.
• W3210347170 hasAuthorship W3210347170A5014096214 @default.
• W3210347170 hasAuthorship W3210347170A5020689634 @default.
• W3210347170 hasAuthorship W3210347170A5024236651 @default.
• W3210347170 hasAuthorship W3210347170A5027231637 @default.
• W3210347170 hasAuthorship W3210347170A5032895748 @default.
• W3210347170 hasAuthorship W3210347170A5034065380 @default.
• W3210347170 hasAuthorship W3210347170A5068410789 @default.
• W3210347170 hasAuthorship W3210347170A5078251698 @default.
• W3210347170 hasAuthorship W3210347170A5081135420 @default.
• W3210347170 hasAuthorship W3210347170A5086028372 @default.
• W3210347170 hasBestOaLocation W32103471701 @default.
• W3210347170 hasConcept C121608353 @default.
• W3210347170 hasConcept C126322002 @default.
• W3210347170 hasConcept C126838900 @default.
• W3210347170 hasConcept C141071460 @default.
• W3210347170 hasConcept C143998085 @default.
• W3210347170 hasConcept C2776694085 @default.
• W3210347170 hasConcept C2777063308 @default.
• W3210347170 hasConcept C2777506904 @default.
• W3210347170 hasConcept C2777532014 @default.
• W3210347170 hasConcept C2778239845 @default.
• W3210347170 hasConcept C2778292576 @default.
• W3210347170 hasConcept C2778424827 @default.
• W3210347170 hasConcept C2909463153 @default.
• W3210347170 hasConcept C509974204 @default.
• W3210347170 hasConcept C530470458 @default.
• W3210347170 hasConcept C71924100 @default.
• W3210347170 hasConceptScore W3210347170C121608353 @default.
• W3210347170 hasConceptScore W3210347170C126322002 @default.
• W3210347170 hasConceptScore W3210347170C126838900 @default.
• W3210347170 hasConceptScore W3210347170C141071460 @default.
• W3210347170 hasConceptScore W3210347170C143998085 @default.
• W3210347170 hasConceptScore W3210347170C2776694085 @default.
• W3210347170 hasConceptScore W3210347170C2777063308 @default.
• W3210347170 hasConceptScore W3210347170C2777506904 @default.
• W3210347170 hasConceptScore W3210347170C2777532014 @default.
• W3210347170 hasConceptScore W3210347170C2778239845 @default.
• W3210347170 hasConceptScore W3210347170C2778292576 @default.
• W3210347170 hasConceptScore W3210347170C2778424827 @default.
• W3210347170 hasConceptScore W3210347170C2909463153 @default.
• W3210347170 hasConceptScore W3210347170C509974204 @default.
• W3210347170 hasConceptScore W3210347170C530470458 @default.
• W3210347170 hasConceptScore W3210347170C71924100 @default.
• W3210347170 hasFunder F4320320873 @default.
• W3210347170 hasIssue "12" @default.
• W3210347170 hasLocation W32103471701 @default.
• W3210347170 hasLocation W32103471702 @default.
• W3210347170 hasLocation W32103471703 @default.
• W3210347170 hasLocation W32103471704 @default.

• next